Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.030
-0.070 (-1.71%)
At close: Aug 28, 2026, 4:00 PM EDT
4.035
+0.005 (0.12%)
After-hours: Aug 28, 2026, 4:10 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $95.93 million as of August 28, 2026. Its market cap has increased by 66.54% in one year.
Market Cap
95.93M
Enterprise Value
3.80M
1-Year Change
66.54%
Ranking
Category
Stock Price
$4.03
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $95.93M, a decrease of -55.28%. That is a compound annual growth rate of -42.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 95.93M | -39.22% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 102.98M |
| Polaryx Therapeutics | 102.68M |
| Verrica Pharmaceuticals | 97.75M |
| Adicet Bio | 97.52M |
| Cognition Therapeutics | 97.00M |
| Pelthos Therapeutics | 94.68M |
| Fortress Biotech | 92.38M |
| Atara Biotherapeutics | 92.35M |